Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 19.
doi: 10.1007/s10787-025-02037-w. Online ahead of print.

Dexamethasone modulates cytokine and chemokine secretion by CD4 + T cells from SSc patients and exerts antifibrotic effects in HOCl-induced SSc mice

Maria Eduarda de Oliveira Gonçalves  1 , Anderson Rodrigues de Almeida  2   3 , Andréa Tavares Dantas  4 , Karen Steffani Silva Florencio  1 , Júlia Roberta da Silva Ferreira  1 , Felipe Henrique Dos Santos Barbosa  1 , Ryan Cordeiro Silva  1 , Anderson Arnaldo da Silva  5 , Daniel Neri da Matta  4 , Angela Luzia Branco Pinto Duarte  4 , Moacyr Jesus Barreto de Melo Rêgo  1 , Michelly Cristiny Pereira  1 , Maira Galdino da Rocha Pitta  1
Affiliations

Dexamethasone modulates cytokine and chemokine secretion by CD4 + T cells from SSc patients and exerts antifibrotic effects in HOCl-induced SSc mice

Maria Eduarda de Oliveira Gonçalves et al. Inflammopharmacology. .

Abstract

The use of glucocorticoids in systemic sclerosis (SSc) is restricted due to adverse effects. Despite this, a large proportion of patients still use these medications. Their pharmacological effects on the disease are not completely known; few studies have explored them, and the results are controversial. Thus, the present study aimed to investigate the immunomodulatory and antifibrotic activity of Dexamethasone (Dex) in SSc. The effects were evaluated in CD4 + T lymphocytes and macrophages from 20 SSc patients and 10 healthy volunteers and in a murine model of SSc. Cytokines (IL-4, IL-6, IL-13, IL-17A, and TNF) and chemokines (RANTES, IL-8, MIG, and IP-10) were quantified by sandwich enzyme-linked immunosorbent assay (ELISA) or cytometric bead array (CBA) in cell culture supernatant. Balb/c mice received intradermal injections of hypochlorous acid (HOCl) and treatment with Dex (1 mg/kg) by intraperitoneal injections for 6 weeks. RT-qPCR and histological analysis assessed dermal and pulmonary fibrosis. In the supernatant of CD4 + T lymphocytes, Dex reduced the secretion of IL-4 and IL-13 (p < 0.0001 for both), IL-6 (p = 0.0023) and TNF (p = 0.0005), in addition to the chemokines IP-10, MIG, RANTES, IL-8 (p < 0.0001 for all). Furthermore, Dex treatment SSc mice significantly reduced dermal thickening (p < 0.0001), mRNA expression of Col1a1 (p = 0.002), Tgfβ1 (p < 0.0001) and Acta2 (p < 0.0001) in the skin, and Tgfβ1 (p = 0.005) in the lungs. Furthermore, it reduced IL-4 secretion (p = 0.02) in the splenocyte culture supernatant. In summary, Dex showed immunomodulatory and antifibrotic effects in SSc, evidencing its actions in treating the disease.

Keywords: Autoimmunity; CD4 + T lymphocytes; Fibrosis; Scleroderma; Treatment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare that there are no conflicts of interest. Ethics approval: The study protocol that involved collection of blood and clinical data from human beings was evaluated and approved by the ethics committee for research with human beings of the Health Sciences Center of the Universidade Federal de Pernambuco, under CAAE nº: 58725722.8.0000.5208 and Nº of opinion: 6.314.837. The study protocol involving animals was evaluated and approved by the Ethics Committee on the Use of Animals (CEUA) of the Universidade Federal de Pernambuco, process no 0067/2022.

References

    1. Ai F, Zhao G, Lv W et al (2020) Dexamethasone induces aberrant macrophage immune function and apoptosis. Oncol Rep 43:427–436. https://doi.org/10.3892/or.2019.7434 - DOI - PubMed
    1. Bobeica C, Niculet E, Tatu A et al (2021) Old and new therapeutic strategies in systemic sclerosis (Review). Exp Ther Med 23:1–6. https://doi.org/10.3892/etm.2021.11057 - DOI
    1. Dantas AT, de Almeida AR, Sampaio MCPD et al (2017) Corticosteroid inhibits chemokines production in systemic sclerosis patients. Steroids 127:24–30. https://doi.org/10.1016/j.steroids.2017.08.012 - DOI - PubMed
    1. De Almeida AR, Dantas AT, Pereira MC et al (2019) Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients. Inflammopharmacology 27:723–730. https://doi.org/10.1007/s10787-019-00600-w - DOI - PubMed
    1. De Almeida AR, Dantas AT, de Oliveira Gonçalves ME et al (2023) PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients. Inflammopharmacology. https://doi.org/10.1007/s10787-023-01296-9 - DOI - PubMed

LinkOut - more resources